Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

49 results about "Brain hemorrhages" patented technology

Hemorrhage in the brain refers to bleeding in the brain that can occur in the brain, between the membranes that cover the brain, or between the skull and the brain covering. Brain hemorrhages are also known as intracranial hemorrhages, cerebral hemorrhages, or intracerebral hemorrhages.

Analytical method for beta-amyloid protein pathology by using thioflavine T staining

InactiveCN103278626AClear etiologyStrong impetusFluorescence/phosphorescencePharmacological interventionsDisease patient
The invention relates to an analytical method for beta-amyloid protein pathology by using thioflavine T staining. The method comprises the following processes: A, a patient pathological specimen source, B, an experimental animal pathological specimen source, C, treatment of patient and experimental animal brain tissue specimens, D, immumohistochemical staining of specimen beta-amyloid protein 1-42, E, thioflavine T staining of the specimen, and F, optical / fluorescence microscope pathological examination. The method has the advantages of introducing and widely using the thioflavine T to mark an amyloid protein disease patient brain tissue pathological specimen and assess the pharmacological intervention effect of alzheimer disease (AD) transgenic animals; compared with the traditional silver staining method and A beta immunohistochemical method, the method provided by the invention has the characteristics of being simple and feasible, and sensitive and reliable, is beneficial for clearing the nosetiology of cerebral hemorrhage, and has great guide value on formulation of patient secondary intervening measures. The wide application of the technology has a powerful promoting effect on clinical pathological research and translational medicine research of the A beta related diseases (alzheimer disease and amyloid angiopathy).
Owner:徐俊

3D printing cerebral hemorrhage model for puncture training and efficient manufacturing method thereof

According to the 3D printing cerebral hemorrhage model for puncture training and the efficient manufacturing method of the 3D printing cerebral hemorrhage model, the smooth interface of an upper skull and a lower skull is limited and combined through a limiting groove and a limiting boss to form the whole simulation skull, a flexible simulated hematoma block is installed in the lower skull through a skull seat, and the simulation skull is further filled with a flexible simulated brain tissue; the simulated brain tissue wraps the simulated hematoma block, and the simulated brain tissue and the simulated hematoma block are made of transparent materials; after a 3D model is created by imitating any real cerebral hemorrhage case clinically, an individualized model is manufactured through a 3D printing technology and is used for practical puncture operation training; pathophysiological changes of cerebral hemorrhage can be completely simulated, and puncture experience of the model is vivid; after the operation is completed, the path deformation of the puncture needle can be visually inspected through the transparent simulated brain tissue and the simulated hematoma block, and the puncture effect can be clearly judged; and the device is accurate in position, can be repeatedly used or recycled, and is simple in structure, low in cost and convenient to operate.
Owner:SUN YAT SEN UNIV CANCER CENT +1

Cerebral hemorrhage CT image classification method based on image sequence analysis

The invention discloses a cerebral hemorrhage CT image classification method based on image sequence analysis. The method belongs to the technical field of medical image analysis, and the operation process comprises the steps of brain CT image data acquisition, data imaging processing, model construction and classification method implementation. The method comprises the following specific operation steps: acquiring a brain CT scanning result to obtain brain CT image original data; performing imaging processing on the original data of the brain CT image to form a three-channel image sequence as the input of a subsequent model; constructing a model comprising a channel attention module and a space attention module to extract features of the three-channel image sequence; according to the method, the model is trained to optimize parameters, cerebral hemorrhage positive is recognized, cerebral hemorrhage subtypes are distinguished, cerebral hemorrhage CT images are classified, CT scanning image information can be fully utilized by the model, attention to key information in an image sequence is improved, the judgment process of the whole method conforms to the diagnosis process of doctors in a real scene, and the diagnosis efficiency is improved. And the cerebral hemorrhage classification effect can be improved.
Owner:NANJING UNIV OF AERONAUTICS & ASTRONAUTICS

Soft capsules for treating apoplexy and preparation method thereof

The invention relates to soft capsules for treating apoplexy and a preparation method thereof. The inside of each soft capsule shell is extracts of sanguisuge and raidx astragali, also can be added with extracts of auxiliary Chinese medicaments, such as sanchi, snakegourd fruit, earthworm, ginseng and the like, and is added with relevant auxiliary materials, i.e. a dispersing agent, a suspending agent, an antioxygen, a preservative and the like. The preparation method for the soft capsules comprises the following steps: heating, stirring and melting glycerin, distilled water and expanded gelatin in a gelatin pot; adding the preservative in the gelatin pot; adding the extracts of sanguisuge and raidx astragali, the extracts of other auxiliary Chinese medicaments and liquid melt of beeswax and seed fat; and stirring the mixture into the uniform semi-solid substance. The soft capsules whose effective components are highly dispersed in the substrate are prepared by a pressing method or a dropping preparation method. The soft capsules comprising the extract of sanguisuge and raidx astragali are used for activating blood, eliminating stasis, promoting blood circulation and relieving pain, are suitable to treat meridian qi deficiency and blood stasis type cerebral infarction symptoms in the apoplexy, coronary heart disease, angina, acute myocardial infarction and ischemic cerebral apoplexy, can obviously reduce arteria vertebralis resistance and improve cerebral ischemia and brain circulation, and also can be used for disseminated intravascular coagulation and absorption of intracerebral hematoma of cerebral hemorrhage convalescence and sequelae. The soft capsules of the invention have physicochemical property, stable drug effect and high bioavailability, and can cover bad taste and odor of the medicament.
Owner:HEBEI RUISHENG PHARMA

Application of polysaccharide in medicament for treating or preventing primary cerebral hemorrhage

The invention relates to novel application of the medical effect of polysaccharide, in particular to application of polysaccharide in a medicament for treating or preventing primary cerebral hemorrhage. An SD (Sprague Dawley) rat cerebral hemorrhage model is used as an experimental material, and the polysaccharide is used for treating an SD rat with primary cerebral hemorrhage neuronal damage, no matter the drug administration is carried out before or after the model, the polysaccharide has the effect of reducing encephaledema (BBB, brain blood barrier) in the cerebral hemorrhage model; drug administration before hemorrhage indicates that the inhibition ratios to brain water content (BBB) are respectively 10.4 percent and 13.3 percent if dosages are 60 and 100mg / kg, and the prevention effect is good; and drug administration before hemorrhage indicates that the inhibition ratios to the brain water content (BBB) are respectively 9.5 percent and 12 percent if dosages are 60 and 100mg / kg. The remarkable medical effect of the polysaccharide in cerebral hemorrhage treatment before clinical application indicates the clinical treatment practicability of polysaccharide in cerebral hemorrhage treatment. The polysaccharide can be used as a prevention medicament and a treatment medicament to improve the cure rate and survival rate of cerebral hemorrhage and has good treatment effect.
Owner:XUZHOU MEDICAL COLLEGE

Cerebral hemorrhage point intelligent detection method and device and computer readable storage medium

The invention relates to an artificial intelligence technology, and discloses an intelligent cerebral hemorrhage point detection method. The method comprises the steps of obtaining a brain medical image set and obtaining a readable brain image set based on a parameter adjustment algorithm, dividing the readable brain image set into a training set and a test set, inputting the training set into anoriginal cerebral hemorrhage point detection model for training to obtain a cerebral hemorrhage point detection model, inputting the test set into the cerebral hemorrhage point detection model to obtain a test value, and after the test value meets the preset requirement, enabling the brain bleeding point detection model to complete the training, receive a brain picture, input the brain picture into the brain bleeding point detection model to obtain a brain bleeding point coordinate, and editing, arranging and outputting a brain bleeding point based on a bleeding point operation platform and the brain bleeding point coordinate. The invention further provides a cerebral hemorrhage point intelligent detection device and a computer readable storage medium. The cerebral hemorrhage point detection method and device can realize an accurate and efficient cerebral hemorrhage point detection function.
Owner:PING AN TECH (SHENZHEN) CO LTD

Modeling method of mouse hypertensive cerebral hemorrhage model

The invention discloses a modeling method of a mouse hypertensive cerebral hemorrhage model, which comprises the following steps of: puncturing and taking blood from the left ventricle of a mouse, exposing a skull surgery field by wiping and cleaning soft tissues covering the skull, drilling after determining a needle insertion point on the surface of the skull, injecting autologous blood at the drilling position through a brain stereotaxic instrument, and then injecting the autologous blood into the mouse hypertensive cerebral hemorrhage model; and after injection is completed, sealing the drilled hole with bone wax, disinfecting the incision, and suturing the skin. According to the method, arterial blood is taken through left ventricle puncture, the survival rate of a mouse is not reduced on the premise that sufficient arterial blood is extracted, autologous arterial blood is accurately injected back into the tail shell core of the basal segment in the brain through a mouse brain locator, and stable hematoma is formed. The method provides guarantee for subsequent experiments, is beneficial to experimental contrast research, is very similar to clinical pathological changes and disease outcome of hypertension patients, and has important significance on disease outcome and treatment schemes after cerebral hemorrhage.
Owner:XUZHOU MEDICAL UNIV

Application of apolipoprotein E receptor mimetic peptide 6KApoEp in preparation of medicine for treating secondary brain injury after cerebral hemorrhage

The invention discloses an application of apolipoprotein E receptor mimetic peptide 6KApoEp in preparation of a medicine for treating secondary brain injury after cerebral hemorrhage, and discloses a protein sequence of the apolipoprotein E receptor mimetic peptide 6KApoEp, a construction method of the protein sequence of the apolipoprotein E receptor mimetic peptide 6KApoEp and preparation of an application mixed solution; after the 6KApoEp is applied, the expression of CypA can be reduced; by inhibiting activation of a/MMP-9 pathway, cerebral edema and blood-brain barrier damage after cerebral hemorrhage and generation of proinflammatory factors are relieved; the brain water content is reduced, the BBB permeability is improved, the increase of blood-brain barrier related proteins such as claudin-5, occludin and ZO-1 is promoted, the inflammatory response after cerebral hemorrhage is regulated and controlled by inhibiting CypA/NF-KB/MMP-9, the water content of brain tissues is reduced, and the blood-brain barrier permeability is improved, so that the secondary brain injury after cerebral hemorrhage is relieved, and the neuroprotective effect on cerebral hemorrhage is achieved; the inflammatory response after cerebral hemorrhage is reduced, and the blood-brain barrier permeability is improved.
Owner:王丽琨

A multi-frequency electromagnetic tomography method for the detection of intracerebral hemorrhage

The invention discloses a multi-frequency electromagnetic tomographic method for detection of cerebral hemorrhage. Multiple coils are distributed on the periphery of a detected area, exciting coils are sequentially powered up with alternating excitation currents at different frequencies, detection coils around a detected area produce induced voltages sequentially at different frequencies, and the target cerebral hemorrhage image is reconstructed in steps as follows: the detection voltage difference produced by a brain suffering from cerebral hemorrhage on the detection coils is calculated; phase shift, caused by the brain suffering from cerebral hemorrhage when the frequency of excitation currents is fi, of detection voltage on the detection is calculated; the formula is solved with a Tikhonov regularization method, the phase shift, caused by single tissue j when the reference frequency of the excitation currents is f1, of the detection voltage on the detection coils is acquired; the phase difference, caused by cerebral hemorrhage tissue when the frequency of the excitation currents is between fn and f1, of the detection voltage on the detection coils is calculated; the electric conductivity distribution of the cerebral hemorrhage tissue is solved.
Owner:TIANJIN UNIV

Application of apolipoprotein e receptor mimetic peptide 6kapoep in the preparation of drugs for the treatment of secondary brain injury after cerebral hemorrhage

The invention discloses the application of apolipoprotein E receptor mimic peptide 6KApoEp in the preparation of drugs for treating secondary brain injury after cerebral hemorrhage, and discloses the protein sequence of apolipoprotein E receptor mimic peptide 6KapoEp, apolipoprotein E receptor The construction method of the protein sequence of the analog peptide 6KapoEp, and the preparation of the application mixture, after the application of 6KApoEp, the expression of CypA can be reduced, and the cerebral edema and blood-brain barrier damage and inflammation after cerebral hemorrhage can be alleviated by inhibiting the activation of the MMP-9 pathway Factor production; reduce brain water content, improve BBB permeability, promote the increase of blood-brain barrier-related proteins such as claudin-5, occludin, ZO-1, regulate cerebral hemorrhage by inhibiting CypA / NF-KB / MMP-9 Post-inflammatory response, reduce brain tissue water content, improve blood-brain barrier permeability, thereby reducing secondary brain damage after cerebral hemorrhage, play a neuroprotective role in cerebral hemorrhage, reduce post-cerebral hemorrhage inflammatory response, improve blood-brain barrier permeability permeability effect.
Owner:王丽琨
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products